CellBion Co., Ltd. (KOSDAQ:308430)
South Korea · Delayed Price · Currency is KRW 17,090
-90 (-0.52%)
At close: Jul 3, 2026
CellBion Market Cap
CellBion has a market cap or net worth of 220.55 billion as of July 2, 2026. Its market cap has decreased by -13.44% in one year.
Market Cap
220.55B
Enterprise Value
208.64B
Revenue
2.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
17,090.00
Market Cap Chart
Since October 16, 2024, CellBion's market cap has decreased from 263.06B to 220.55B, a decrease of -16.16%. That is a compound annual growth rate of -9.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 220.55B | -27.17% |
| Dec 30, 2025 | 302.82B | 100.48% |
| Dec 30, 2024 | 151.05B | -42.58% |
| Oct 16, 2024 | 263.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samyang Biopharm | 356.18B |
| ImmuneOncia Therapeutics | 310.78B |
| HEM Pharma | 297.45B |
| NOVAREX | 227.07B |
| DAE HWA Pharmaceutical | 162.03B |
| Vivozon Pharmaceutical | 151.01B |
| GC WellBeing | 148.68B |
| Cosmax Nbt | 136.07B |